InterCure Operating Income 2022-2024 | INCR

InterCure operating income from 2022 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

InterCure Operating Income 2022-2024 | INCR

InterCure operating income from 2022 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229.7B
Boston Scientific (BSX)$152.7B
Stryker (SYK)$148.7B
EssilorLuxottica (ESLOY)$131.4B
Medtronic (MDT)$115.3B
Lonza Group Ag (LZAGY)$51.1B
Haleon (HLN)$44.7B
ResMed (RMD)$37.3B
Agilent Technologies (A)$35B
GE HealthCare Technologies (GEHC)$34.4B
Terumo (TRUMY)$24.6B
Koninklijke Philips (PHG)$23.1B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$18.6B
Baxter (BAX)$14.7B
Smith & Nephew SNATS (SNN)$13.3B
Demant (WILYY)$9B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$7B
Lantheus Holdings (LNTH)$5.6B
Perrigo (PRGO)$3.8B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
ICU Medical (ICUI)$3.3B
QuidelOrtho (QDEL)$2.1B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.5B
Acuren (TIC)$1.4B